3-Year Update from the EPCORE NHL-1 Trial: Epcoritamab SC Leads to Deep and Durable Responses in Relapsed or Refractory Large B-Cell Lymphoma

Kim Linton, et al.

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Article number4480
JournalBlood
Volume144
Issue numberS1
DOIs
Publication statusPublished - 5 Nov 2024
Event66th ASH Annual Meeting & Exposition - San Diego, United States
Duration: 7 Dec 202410 Dec 2024
https://www.hematology.org/meetings/annual-meeting/schedule-and-program

Cite this